title: Assessment of antihypertensive effect by blood pressure monitoring: applications to bisoprolol and lisinopril in a double-blind study.
abstract: The aim of this study was to evaluate the antihypertensive effect of drugs according to the initial ambulatory blood pressure (BP) level. After a 15-day placebo run-in period, 105 patients with moderate essential hypertension (mean age, 52 years) underwent 24-h BP monitoring (spacelabs: 1 measure/15 min). Patients were subdivided into two groups: the "High" group, with 24-h mean values of systolic BP (SBP) > 137 or diastolic BP (DBP) > 87 mm Hg, and the "Low" group, with SBP < or = 137 and DBP < or = 87 mm Hg. All patients received, in a random and double-blind design, either bisoprolol (10 mg q.d.) or lisinopril (20 mg q.d.) for 8 weeks. At the end of this active treatment period, office and ambulatory BP measurements were performed. Casual measurements revealed similar BP decreases in all subgroups receiving bisoprolol and lisinopril; BP monitoring showed that the antihypertensive effect depended on the baseline mean 24-h value; -15/-12 mm Hg for bisoprolol and -18/-13 mm Hg for lisinopril in the High group; -7/-6 mm Hg for bisoprolol and -6/-6 mm Hg for lisinopril in the Low group. This study shows that the antihypertensive effect depended on initial ambulatory BP values, with a lower BP decrease in the Low group. Assessment of the antihypertensive effect on ambulatory BP is useful in clinical trials.
authors.affiliation: Service de Médecine Interne à Orientation Angéiologique, Hôpital de la Timone, Marseille, France.
authors.forename: B
authors.initials: B
authors.lastname: Vaïsse
authors.forename: D
authors.initials: D
authors.lastname: Herpin
authors.forename: R
authors.initials: R
authors.lastname: Asmar
authors.forename: P
authors.initials: P
authors.lastname: Battistella
authors.forename: F
authors.initials: F
authors.lastname: Zannad
authors.forename: S
authors.initials: S
authors.lastname: Boutelant
authors.forename: A
authors.initials: A
authors.lastname: Lyon
authors.forename: D
authors.initials: D
authors.lastname: Conte
authors.forename: J
authors.initials: J
authors.lastname: Denis
authors.forename: P
authors.initials: P
authors.lastname: Honore
authors.forename: S
authors.initials: S
authors.lastname: Contard
authors.forename: P L
authors.initials: PL
authors.lastname: Prost
authors.forename: J M
authors.initials: JM
authors.lastname: Mallion
authors.forename: L
authors.initials: L
authors.lastname: Poggi
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D017298:Bisoprolol / Q000627:therapeutic use*; D018660:Blood Pressure Monitoring, Ambulatory; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology*; D017706:Lisinopril / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged
chemical_list: D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D017706:Lisinopril; D017298:Bisoprolol